The billion-dollar gamble: Biotech CEO takes a risky second shot at an Alzheimer’s drug – STAT
September 7, 2017 by admin
Filed under Alzheimers News
Sponsored By
 STAT |
The billion-dollar gamble: Biotech CEO takes a risky second shot at an Alzheimer's drug
STAT Medivation, a California startup, was developing a treatment for Alzheimer's disease, and pivotal results from a major clinical trial were finally available. An earlier study, conducted in Russia, had generated what Alzheimer's experts hailed as the … |
More Info: Click here